Show simple item record

dc.contributor.authorRanson, Malcolm R
dc.contributor.authorWhite, Shane C
dc.contributor.authorThatcher, Nick
dc.date.accessioned2009-11-19T17:02:22Z
dc.date.available2009-11-19T17:02:22Z
dc.date.issued2000-01
dc.identifier.citationManagement of elderly patients with lung cancer. 2000, 2 (1):90-5 Curr Oncol Repen
dc.identifier.issn1523-3790
dc.identifier.pmid11122829
dc.identifier.doi10.1007/s11912-000-0015-y
dc.identifier.urihttp://hdl.handle.net/10541/86535
dc.description.abstractCancer management in the older patient is a growing concern, particularly with the increasing geriatric population and the high incidence of cancer among these individuals. Incidence of lung cancer in particular is known to rise with age. This article reviews prognosis, treatment options, and decision-making issues for both clinician and patient with respect to both non-small-cell and small-cell lung cancer in this population. Research findings dealing with response rates, survival rates, and symptom control in this age group are reviewed for radiotherapy, surgery, and for various chemotherapy agents, including gemcitabine, the taxanes, vinorelbine, and the topoisomerase 1 inhibitors. Quality- of-life issues are also addressed.
dc.language.isoenen
dc.subjectLung Canceren
dc.subject.meshAge Factors
dc.subject.meshAged
dc.subject.meshAntineoplastic Agents, Phytogenic
dc.subject.meshBridged Compounds
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.meshCarcinoma, Small Cell
dc.subject.meshCombined Modality Therapy
dc.subject.meshDecision Making
dc.subject.meshDeoxycytidine
dc.subject.meshGeriatrics
dc.subject.meshHumans
dc.subject.meshLung Neoplasms
dc.subject.meshPrognosis
dc.subject.meshQuality of Life
dc.subject.meshSurvival Analysis
dc.subject.meshTaxoids
dc.subject.meshVinblastine
dc.titleManagement of elderly patients with lung cancer.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, Christie Hospital NHS Trust and Holt Radium Institute, Wilmslow Road, Manchester M20 4BX, United Kingdom.en
dc.identifier.journalCurrent Oncology Reportsen
html.description.abstractCancer management in the older patient is a growing concern, particularly with the increasing geriatric population and the high incidence of cancer among these individuals. Incidence of lung cancer in particular is known to rise with age. This article reviews prognosis, treatment options, and decision-making issues for both clinician and patient with respect to both non-small-cell and small-cell lung cancer in this population. Research findings dealing with response rates, survival rates, and symptom control in this age group are reviewed for radiotherapy, surgery, and for various chemotherapy agents, including gemcitabine, the taxanes, vinorelbine, and the topoisomerase 1 inhibitors. Quality- of-life issues are also addressed.


This item appears in the following Collection(s)

Show simple item record